text
"['\n2. 연결재무제표\n(1) 재무상태표\n분\xa0\xa0 기\xa0\xa0 연\xa0\xa0 결\xa0\xa0 재\xa0\xa0 무\xa0\xa0 상\xa0\xa0 태\xa0\xa0 표\n제 65 기 3분기 :\xa0 2020년 09월 30일 현재\n제 64 기\xa0 \xa0 \xa0 \xa0\xa0 :\xa0 2019년 12월 31일 현재\n제 63 기\xa0 \xa0 \xa0 \xa0\xa0 :\xa0 2018년 12월 31일 현재\n삼성생명보험주식회사와 그 종속기업\n(단위 : 백만원)\n과\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 목\n제 65기 3분기(2020년 9월말)\n제 64 기(2019년 12월말)\n제 63 기(2018년 12월말)\n\xa0Ⅰ.현금및현금성자산\n2,832,999\n5,207,649\n3,434,345\xa0\n\xa0Ⅱ.당기손익인식금융자산\n5,438,599\n4,072,253\n3,488,145\xa0\n\xa0Ⅲ.매도가능금융자산\n172,784,714\n166,997,576\n147,638,963\xa0\n\xa0Ⅳ.만기보유금융자산\n280,027\n280,147\n280,873\xa0\n\xa0V.대출채권및기타수취채권\n76,495,174\n71,754,486\n73,182,513\xa0\n\xa0Ⅵ.위험회피목적파생상품자산\n559,871\n561,431\n710,094\xa0\n\xa0Ⅶ.관계기업투자\n1,498,263\n1,379,148\n1,346,611\xa0\n\xa0Ⅷ.금융리스채권\n147,422\n237,508\n376,524\xa0\n\xa0IX.매각예정자산\n74\n98,637\n-\n\xa0X.투자부동산\n6,857,564\n6,448,735\n7,297,969\xa0\n\xa0XI.유형자산\n703,341\n735,119\n822,577\xa0\n\xa0XII.무형자산\n676,210\n743,372\n850,605\xa0\n\xa0XIII.사용권자산\n210,673\n206,188\n-\n\xa0XIV.당기법인세자산\n290,669\n527,715\n1,187\xa0\n\xa0XV.이연법인세자산\n504\n1,012\n991\xa0\n\xa0XVI.기타자산\n3,309,236\n3,715,998\n4,062,368\xa0\n\xa0XVII.특별계정자산\n53,284,073\n49,795,298\n45,933,890\xa0\n자\xa0 \xa0 \xa0\xa0 산\xa0 \xa0 \xa0\xa0 총\xa0 \xa0 \xa0\xa0 계\n325,369,413==================\n312,762,272==================\n289,427,655 ==================\nⅠ.보험계약부채\n186,617,025\n180,492,968\n173,943,448\xa0\nⅡ.계약자지분조정\n12,391,767\n11,528,465\n8,208,565\xa0\nⅢ.당기손익인식금융부채\n245,175\n139,237\n19,419\xa0\nⅣ.기타금융부채\n22,806,188\n20,377,319\n22,484,393\xa0\nⅤ.위험회피목적파생상품부채\n700,394\n455,285\n266,692\xa0\nⅥ.당기법인세부채\n107,879\n138,986\n363,813\xa0\nⅦ.이연법인세부채\n8,512,160\n7,850,375\n5,293,854\xa0\nⅧ.충당부채\n307,816\n251,896\n335,416\xa0\nⅨ.기타부채\n1,213,882\n1,067,791\n1,029,980\xa0\nX.특별계정부채\n53,034,865\n53,143,545\n46,976,616\xa0\n부\xa0 \xa0 \xa0\xa0 채\xa0 \xa0 \xa0\xa0 총\xa0 \xa0 \xa0\xa0 계\n285,937,151\n275,445,867\n258,922,196\xa0\n\u3000\nⅠ.지배기업지분\n37,746,545\n35,667,037\n28,902,094\xa0\n\xa0 1.자본금\n100,000\n100,000\n100,000\xa0\n\xa0 2.자본잉여금\n125,115\n125,115\n125,115\xa0\n\xa0 3.자본조정\n(2,116,955)\n(2,116,955)\n(2,116,955)\n\xa0 4.기타포괄손익누계액\n23,084,863\n21,509,453\n15,245,998\xa0\n\xa0 5.이익잉여금\n16,553,522\n16,049,424\n15,547,936\xa0\nⅡ.비지배지분\n1,685,717\n1,649,368\n1,603,365\xa0\n자\xa0 \xa0 \xa0\xa0 본\xa0 \xa0 \xa0\xa0 총\xa0 \xa0 \xa0\xa0 계\n39,432,262\n37,316,405\n30,505,459\xa0\n부\xa0\xa0 채\xa0\xa0 와\xa0\xa0 자\xa0\xa0 본\xa0\xa0 총\xa0\xa0 계\n325,369,413==================\n312,762,272 ==================\n289,427,655 ==================\n(2) 포괄손익계산서\n연\xa0\xa0 결\xa0\xa0\xa0포\xa0\xa0 괄\xa0\xa0 손\xa0\xa0 익\xa0\xa0 계\xa0\xa0 산\xa0\xa0 서\n제65기 3분기 :\xa0 2020년 01월 01일부터 2020년 09월 30일까지\n제64기 3분기 :\xa0 2019년 01월 01일부터 2019년 09월 30일까지\n제64기\xa0 :\xa0 2019년 01월 01일부터 2019년 12월 31일까지\n제63기\xa0 :\xa0 2018년 01월 01일부터 2018년 12월 31일까지\n삼성생명보험주식회사와 그 종속기업\n(단위 : 백만원)\n과\xa0 \xa0 \xa0 \xa0 \xa0 목\n제 65 (당) 기 3분기\n제 64 (전) 기 3분기\n제 64 (전) 기\n제 63 (전전) 기\nⅠ.영업수익\n25,775,390\n24,801,203\n31,804,022\xa0\n32,240,885\xa0\n\xa0 1.보험료수익\n13,123,060\n12,141,406\n16,201,074\xa0\n16,134,974\xa0\n\xa0 2.재보험수익\n280,291\n251,324\n389,855\xa0\n340,144\xa0\n\xa0 3.이자수익\n5,314,780\n5,379,944\n7,187,838\xa0\n7,109,193\xa0\n\xa0 4.당기손익인식금융상품관련이익\n1,070,168\n726,402\n722,857\xa0\n555,479\xa0\n\xa0 5.매도가능금융자산관련이익\n445,851\n201,843\n275,872\xa0\n1,247,110\xa0\n\xa0 6.위험회피목적파생상품관련이익\n215,170\n173,288\n144,161\xa0\n290,112\xa0\n\xa0 7.외환거래이익\n792,095\n1,230,648\n811,654\xa0\n640,649\xa0\n\xa0 8.수수료수익\n1,254,695\n1,262,883\n1,680,886\xa0\n1,677,177\xa0\n\xa0 9.배당금수익\n765,976\n826,292\n1,051,509\xa0\n1,081,956\xa0\n\xa0 10.임대료수익\n305,224\n346,398\n450,122\xa0\n420,851\xa0\n\xa0 11.특별계정수입수수료\n1,159,823\n1,225,974\n1,626,473\xa0\n1,653,367\xa0\n\xa0 12.특별계정수익\n533,090\n422,965\n523,644\xa0\n478,535\xa0\n\xa0 13.기타영업수익\n301,765\n355,179\n409,730\xa0\n271,435\xa0\n\xa0 14.리스수익\n213,402\n256,657\n328,347\xa0\n339,903\xa0\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\xa0Ⅱ.영업비용\n24,476,158\n23,565,469\n30,551,441\xa0\n29,657,574\xa0\n\xa0\xa0 1.보험계약부채전입액\n5,750,063\n4,481,958\n6,003,799\xa0\n6,447,570\xa0\n\xa0\xa0 2.지급보험금\n10,548,045\n10,903,846\n14,467,397\xa0\n13,510,288\xa0\n\xa0\xa0 3.재보험비용\n377,208\n326,906\n443,585\xa0\n389,497\xa0\n\xa0\xa0 4.사업비\n1,523,178\n1,648,863\n2,176,339\xa0\n2,231,879\xa0\n\xa0\xa0 5.신계약비상각비\n974,413\n1,090,183\n1,441,454\xa0\n1,556,301\xa0\n\xa0\xa0 6.재산관리비\n208,694\n224,494\n297,321\xa0\n327,313\xa0\n\xa0\xa0 7.이자비용\n374,515\n472,136\n636,789\xa0\n442,153\xa0\n\xa0\xa0 8.당기손익인식금융상품관련손실\n892,171\n451,753\n596,905\xa0\n416,293\xa0\n\xa0\xa0 9.매도가능금융자산관련손실\n151,566\n44,530\n60,872\xa0\n10,486\xa0\n\xa0\xa0 10.대출채권및기타수취채권관련손실\n298,577\n327,128\n440,105\xa0\n399,371\xa0\n\xa0\xa0 11.위험회피목적파생상품관련손실\n576,229\n979,001\n625,671\xa0\n478,883\xa0\n\xa0\xa0 12.외환거래손실\n329,239\n236,548\n230,004\xa0\n365,329\xa0\n\xa0\xa0 13.특별계정비용\n533,090\n422,965\n523,644\xa0\n478,535\xa0\n\xa0\xa0 14.기타영업비용\n1,939,170\n1,955,158\n2,607,556\xa0\n2,603,676\xa0\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\nⅢ.영업이익\n1,299,232\n1,235,734\n1,252,581\xa0\n2,583,311\xa0\n\u3000\n\u3000\n\u3000\n\u3000\nⅣ.영업외수익\n132,455\n180,837\n211,824\xa0\n364,121\xa0\n\u3000\n\u3000\n\u3000\n\u3000\nⅤ.영업외비용\n33,159\n15,199\n37,616\xa0\n581,731\xa0\n\u3000\n\u3000\n\u3000\n\u3000\nⅥ.법인세비용차감전연결순이익\n1,398,528\n1,401,372\n1,426,789\xa0\n2,365,701\xa0\n\u3000\n\u3000\n\u3000\n\u3000\nⅦ.법인세비용\n326,664\n368,064\n375,097\xa0\n631,991\xa0\n\u3000\n\u3000\n\u3000\n\u3000\nⅧ.당(분)기연결순이익\n1,071,864\n1,033,308\n1,051,692\xa0\n1,733,710\xa0\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\nⅨ.법인세비용차감후기타포괄손익\n1,568,551\n6,538,684\n6,269,724\xa0\n(1,849,565)\n\xa0 1. 후속적으로 당기손익으로 재분류될 수 있는 항목\n\u3000\n\u3000\n\u3000\n\xa0 \xa0 가.매도가능금융자산평가손익\n1,471,787\n6,268,843\n6,200,063\xa0\n(2,039,534)\n\xa0 \xa0 나.만기보유금융자산평가손익\n-\n0\n-\n(16)\n\xa0 \xa0 다.위험회피목적파생상품평가손익\n(52,253)\n63,455\n(37,789)\n146,675\xa0\n\xa0 \xa0 라.관계기업의 기타포괄손익지분\n4,809\n12,093\n10,771\xa0\n2,387\xa0\n\xa0 \xa0 마.특별계정기타포괄손익\n88,297\n127,765\n97,423\xa0\n45,544\xa0\n\xa0 \xa0 바.해외사업환산손익\n58,721\n68,203\n28,352\xa0\n15,102\xa0\n\xa0 2. 당기손익으로 재분류되지 않는 항목\n\u3000\n\u3000\n\u3000\n\xa0 \xa0 가.순확정급여부채의 재측정요소\n(2,810)\n(1,675)\n(29,096)\n(19,723)\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\nⅩ.당(분)기연결총포괄이익\n2,640,415\n7,571,992\n7,321,416\xa0\n(115,855)\n\u3000\n\u3000\n\u3000\n\u3000\n\xa0\xa0 1.당(분)기연결순이익의 귀속\n1,071,864\n1,033,308\n1,051,692\xa0\n1,733,710\xa0\n\xa0 \xa0 \xa0 지배기업의소유지분\n995,107\n976,788\n977,391\xa0\n1,664,382\xa0\n\xa0 \xa0 \xa0 비지배지분\n76,757\n56,520\n74,301\xa0\n69,328\xa0\n\u3000\n\u3000\n\u3000\n\u3000\n\xa0\xa0 2.당(분)기연결총포괄이익의 귀속\n2,640,415\n7,571,992\n7,321,416\xa0\n(115,855)\n\xa0 \xa0 \xa0 지배기업의소유지분\n2,570,517\n7,511,317\n7,240,846\xa0\n(163,146)\n\xa0 \xa0 \xa0 비지배지분\n69,898\n60,675\n80,570\xa0\n47,291\xa0\n\u3000\n\u3000\n\u3000\n\u3000\nXI.지배기업지분에 대한 주당이익(단위: 원)\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\xa0 기본주당이익\n5,541\n5,439\n5,443\xa0\n9,268\xa0\n\xa0 희석주당이익\n5,541\n5,439\n5,443\xa0\n9,268\xa0\n(3) 자본변동표\n연\xa0\xa0 결\xa0\xa0 자\xa0\xa0 본\xa0\xa0 변\xa0\xa0 동\xa0\xa0 표\n제65기 3분기 :\xa0 2020년 01월 01일부터 2020년 09월 30일까지\n제64기 3분기 :\xa0 2019년 01월 01일부터 2019년 09월 30일까지\n제64기\xa0 :\xa0 2019년 01월 01일부터 2019년 12월 31일까지\n제63기\xa0 :\xa0 2018년 01월 01일부터 2018년 12월 31일까지\n삼성생명보험주식회사와 그 종속기업\n(단위 : 백만원)\n과\xa0 목\n지배기업 소유지분\n비지배지분\n총 계\n자본금\n자본잉여금\n자본조정\n기타포괄손익누계액\n이익잉여금\n지배기업소유지분소 계\n2018. 1.1 (전전기초)\n100,000\n63,084\n(2,116,955)\n17,073,526\n14,239,292\n29,358,947\n1,762,625\n31,121,572\n회계정책변경효과\n-\n-\n-\n-\n2,949\n2,949\n-\n2,949\n수정후 금액\n100,000\n63,084\n(2,116,955)\n17,073,526\n14,242,241\n29,361,896\n1,762,625\n31,124,521\nⅠ.당기연결총포괄손익\n\xa0\xa0 1. 당기연결순이익\n-\n-\n-\n-\n1,664,382\n1,664,382\n69,328\n1,733,710\n\xa0\xa0 2. 매도가능금융자산평가손익\n-\n-\n-\n(2,031,781)\n-\n(2,031,781)\n(7,753)\n(2,039,534)\n\xa0\xa0 3. 만기보유금융자산평가손익\n-\n-\n-\n(16)\n-\n(16)\n-\n(16)\n\xa0\xa0 4. 위험회피목적파생상품평가손익\n-\n-\n-\n160,142\n-\n160,142\n(13,467)\n146,675\n\xa0\xa0 5. 관계기업의 기타포괄손익\n-\n-\n-\n2,387\n-\n2,387\n-\n2,387\n\xa0\xa0 6. 특별계정기타포괄손익\n-\n-\n-\n45,544\n-\n45,544\n-\n45,544\n\xa0\xa0 7. 해외사업환산손익\n-\n-\n-\n14,683\n-\n14,683\n419\n15,102\n\xa0\xa0 8. 순확정급여부채재측정요소\n-\n-\n-\n(18,487)\n-\n(18,487)\n(1,236)\n(19,723)\nⅡ.자본에 직접 인식된 내역\n\xa0\xa0 1. 연차배당\n-\n-\n-\n-\n(359,150)\n(359,150)\n(39,528)\n(398,678)\n\xa0\xa0 2. 지분법이익잉여금변동\n-\n-\n-\n-\n463\n463\n-\n463\n\xa0\xa0 3. 기타\n-\n62,031\n-\n-\n-\n62,031\n(167,023)\n(104,992)\n2018. 12.31 (전전기말)\n100,000==========\n125,115==========\n(2,116,955)==========\n15,245,998==========\n15,547,936==========\n28,902,094==========\n1,603,365==========\n30,505,459==========\n2019.1.1(전기초)\n100,000\n125,115\n(2,116,955)\n15,245,998\n15,547,936\n28,902,094\n1,603,365\n30,505,459\nI. 분기연결총포괄손익\n\xa0\xa0 1. 분기연결순이익\n-\n-\n-\n-\n976,788\n976,788\n56,520\n1,033,308\n\xa0\xa0 2. 매도가능금융자산평가손익\n-\n-\n-\n6,259,012\n-\n6,259,012\n9,831\n6,268,843\n\xa0\xa0 3. 위험회피목적파생상품평가손익\n-\n-\n-\n74,627\n-\n74,627\n(11,172)\n63,455\n\xa0\xa0 4. 관계기업의 기타포괄손익\n-\n-\n-\n12,093\n-\n12,093\n-\n12,093\n\xa0\xa0 5. 특별계정기타포괄손익\n-\n-\n-\n127,765\n-\n127,765\n-\n127,765\n\xa0\xa0 6. 해외사업환산손익\n-\n-\n-\n62,705\n-\n62,705\n5,498\n68,203\n\xa0\xa0 7. 순확정급여부채 재측정요소\n-\n-\n-\n(1,673)\n-\n(1,673)\n(2)\n(1,675)\nⅡ.자본에 직접 인식된 내역\n\xa0 1. 연차배당\n-\n-\n-\n-\n(475,873)\n(475,873)\n(37,530)\n(513,403)\n\xa0 2. 지분법이익잉여금변동\n-\n-\n-\n-\n47\n47\n-\n47\n\xa0 3. 기타\n-\n-\n-\n-\n-\n-\n2,964\n2,964\n2019.9.30(전분기말)\n100,000==========\n125,115==========\n(2,116,955)==========\n21,780,527==========\n16,048,898==========\n35,937,585==========\n1,629,474==========\n37,567,059==========\n2020.1.1(당기초)\n100,000\n125,115\n(2,116,955)\n21,509,453\n16,049,424\n35,667,037\n1,649,368\n37,316,405\nⅠ.분기연결총포괄손익\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\xa0\xa0 1. 분기연결순이익\n-\n-\n-\n-\n995,107\n995,107\n76,757\n1,071,864\n\xa0\xa0 2. 매도가능금융자산평가손익\n-\n-\n-\n1,478,568\n-\n1,478,568\n(6,781)\n1,471,787\n\xa0\xa0 3. 위험회피목적파생상품평가손익\n-\n-\n-\n(49,701)\n-\n(49,701)\n(2,552)\n(52,253)\n\xa0\xa0 4. 관계기업의 기타포괄손익\n-\n-\n-\n4,809\n-\n4,809\n-\n4,809\n\xa0\xa0 5. 특별계정기타포괄손익\n-\n-\n-\n88,297\n-\n88,297\n-\n88,297\n\xa0\xa0 6. 해외사업환산손익\n-\n-\n-\n56,247\n-\n56,247\n2,474\n58,721\n\xa0\xa0 7. 순확정급여부채 재측정요소\n-\n-\n-\n(2,810)\n-\n(2,810)\n-\n(2,810)\nⅡ.자본에 직접 인식된 주주와의 거래\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\xa0\xa0 1. 연차배당\n-\n-\n-\n-\n(475,873)\n(475,873)\n(37,530)\n(513,403)\n\xa0\xa0 2. 지분법이익잉여금변동\n-\n-\n-\n-\n17\n17\n-\n17\n\xa0\xa0 3. 유상증자\n-\n-\n-\n-\n-\n-\n3,981\n3,981\n\xa0\xa0 4. 기타\n-\n-\n-\n-\n(15,153)\n(15,153)\n-\n(15,153)\n2020.9.30(당분기말)\n100,000\n125,115\n(2,116,955)\n23,084,863\n16,553,522\n37,746,545\n1,685,717\n39,432,262\n(4) 현금흐름표\n분\xa0\xa0 기\xa0\xa0 연\xa0\xa0 결\xa0\xa0 현\xa0\xa0 금\xa0\xa0 흐\xa0\xa0 름\xa0\xa0 표\n제65기 3분기 :\xa0 2020년 01월 01일부터 2020년 09월 30일까지\n제64기 3분기 :\xa0 2019년 01월 01일부터 2019년 09월 30일까지\n제64기\xa0 :\xa0 2019년 01월 01일부터 2019년 12월 31일까지\n제63기\xa0 :\xa0 2018년 01월 01일부터 2018년 12월 31일까지\n삼성생명보험주식회사와 그 종속기업\n(단위 : 백만원)\n과\xa0 \xa0 \xa0 \xa0 \xa0 목\n제 65 (당) 3분기\n제 64 (전) 3분기\n제 64 (전) 기\n제 63 (전전) 기\nⅠ.영업활동으로부터의 현금흐름\n\u3000\n(784,245)\n5,828,701\n\u3000\n8,644,450\xa0\n\u3000\n1,956,123\xa0\n\xa0\xa0 1. 영업활동에서 창출된 현금흐름\n(6,565,833)\n-\n823,596\n1,954,925\xa0\n\u3000\n(5,225,451)\n\u3000\n\xa0 \xa0 \xa0 가. 당(분)기순이익\n1,071,864\n-\n1,033,308\n1,051,692\xa0\n\u3000\n1,733,710\xa0\n\u3000\n\xa0 \xa0 \xa0 나. 손익조정사항\n1,593,663\n\u3000\n513,204\n791,390\xa0\n\u3000\n595,344\xa0\n\u3000\n\xa0 \xa0 \xa0 다. 자산ㆍ부채의 증감\n(9,231,360)\n\u3000\n(722,916)\n111,843\xa0\n\u3000\n(7,554,505)\n\u3000\n\xa0\xa0 2. 이자의 수취\n5,343,327\n\u3000\n5,235,869\n7,031,226\xa0\n\u3000\n7,051,418\xa0\n\u3000\n\xa0\xa0 3. 이자의 지급\n(288,395)\n\u3000\n(322,432)\n(460,634)\n\u3000\n(421,230)\n\u3000\n\xa0\xa0 4. 배당금 수입\n757,209\n\u3000\n824,896\n1,043,877\xa0\n\u3000\n1,077,663\xa0\n\u3000\n\xa0\xa0 5. 법인세부담액\n(30,553)\n\u3000\n(733,228)\n(924,944)\n\u3000\n(526,277)\n\u3000\nⅡ. 투자활동으로부터의 현금흐름\n\u3000\n(2,499,134)\n\u3000\n(4,428,516)\n\u3000\n(5,665,167)\n\u3000\n(4,411,023)\n\xa0\xa0 1. 매도가능금융자산의 처분\n9,302,930\n-\n6,416,139\n\u3000\n8,474,108\xa0\n\u3000\n10,934,657\xa0\n\u3000\n\xa0\xa0 2. 매도가능금융자산의 취득\n(11,825,865)\n\u3000\n(11,529,424)\n\u3000\n(14,859,272)\n\u3000\n(15,149,903)\n\u3000\n\xa0\xa0 3. 만기보유금융자산의 증감\n-\n\u3000\n-\n\u3000\n16,315\xa0\n\u3000\n\xa0\xa0 4. 위험회피목적파생상품자산의 정산\n(177,099)\n\u3000\n(84,504)\n(188,510)\n\u3000\n36,612\xa0\n\u3000\n\xa0\xa0 5. 관계기업투자주식의 처분\n2,476\n\u3000\n127,007\n127,527\xa0\n\u3000\n3,592\xa0\n\u3000\n\xa0\xa0 6. 관계기업투자주식의 취득\n(51,114)\n\u3000\n(10,371)\n(47,368)\n\u3000\n(10,151)\n\u3000\n\xa0\xa0 7. 투자부동산 및 유형자산의 처분\n4,342\n\u3000\n670,517\n772,523\xa0\n\u3000\n2,067\xa0\n\u3000\n\xa0\xa0 8. 투자부동산 및 유형자산의 취득\n(43,816)\n\u3000\n(102,112)\n(181,408)\n\u3000\n(1,443,356)\n\u3000\n\xa0\xa0 9. 매각예정자산의 처분\n271,500\n\u3000\n-\n\u3000\n994,043\xa0\n\u3000\n\xa0\xa0 10. 무형자산의 처분\n577\n\u3000\n3,289\n5,955\xa0\n\u3000\n5,369\xa0\n\u3000\n\xa0\xa0 11. 무형자산의 취득\n(60,849)\n\u3000\n(67,661)\n(93,278)\n\u3000\n(154,289)\n\u3000\n\xa0\xa0 12. 연결범위변동 등\n77,784\n\u3000\n148,604\n324,556\xa0\n\u3000\n354,021\xa0\n\u3000\nⅢ. 재무활동으로부터의 현금흐름\n\u3000\n908,832\n(2,219,276)\n\u3000\n(1,206,623)\n\u3000\n1,832,879\xa0\n\xa0\xa0 1. 배당금 지급\n(513,403)\n-\n(513,403)\n(513,403)\n\u3000\n(448,514)\n\u3000\n\xa0\xa0 2. 차입금의 차입\n3,719,800\n\u3000\n3,856,000\n5,570,706\xa0\n\u3000\n6,793,699\xa0\n\u3000\n\xa0\xa0 3. 차입금의 상환\n(4,060,000)\n\u3000\n(4,126,000)\n(5,621,000)\n\u3000\n(5,705,800)\n\u3000\n\xa0\xa0 4. 사채의 발행\n8,342,666\n\u3000\n5,880,000\n11,527,926\xa0\n\u3000\n12,150,787\xa0\n\u3000\n\xa0\xa0 5. 사채의 상환\n(6,379,098)\n\u3000\n(7,181,365)\n(12,415,905)\n\u3000\n(11,548,693)\n\u3000\n\xa0\xa0 6. 비지배지분의 증감 등\n(201,133)\n\u3000\n(134,508)\n\u3000\n245,053\xa0\n\u3000\n591,400\xa0\n\u3000\nⅣ. 현금및현금성자산의 순증감\n\u3000\n(2,374,547)\n\u3000\n(819,091)\n\u3000\n1,772,660\xa0\n\u3000\n(622,021)\nⅤ. 기초의 현금및현금성자산\n\u3000\n5,207,649\n\u3000\n3,434,345\n\u3000\n3,434,345\xa0\n\u3000\n4,055,552\xa0\nⅥ. 외화표시 현금및현금성자산에 대한 \xa0 \xa0\xa0 환율변동효과\n\u3000\n(103)\n\u3000\n1,161\n\u3000\n644\xa0\n\u3000\n814\xa0\nⅦ. (분)기말의 현금및현금성자산\n\u3000\n2,832,999\n\u3000\n2,616,415\n\u3000\n5,207,649\xa0\n\u3000\n3,434,345\xa0\n']"
